Dr. Ofer Levy is the director of the Precision Vaccines Program at Boston Children’s Hospital (BCH). He received his bachelor of science in molecular biophysics and biochemistry from Yale College and his medical degree and doctorate from the New York University School of Medicine. Inspired by his wife Sharon’s example, he chose pediatrics and completed both residency and fellowship (infectious diseases) at BCH. He is currently a professor of pediatrics at Harvard Medical School, principal investigator, and a staff physician in pediatric infectious diseases. Dr. Levy is the founder and director of the BCH Precisions Vaccine Program, a platform to enhance collaboration between academia, government, and industry to accelerate and de-risk development of adjuvanted vaccines tailored to vulnerable populations. The Precision Vaccines Laboratory focuses on cutting edge approaches for adjuvanted vaccine development including: (a) modeling vaccine-induced population-specific human immune responses in vitro using a variety of platforms including tissue engineering of three-dimensional microphysiologic systems, (b) systems biology (“omic”) approaches to accelerate and de-risk development of vaccines optimized for populations with distinct immune responses, including those at the extremes of age who suffer the most infections, and (c) adjuvant discovery, development and formulation.
He currently leads National Institutes of Health/National Institute of Allergy and Infectious Diseases Adjuvant Discovery and Development Program contracts, leveraging cutting edge robotic and immunologic approaches to discover, characterize, and formulate novel small molecule adjuvants that may enhance vaccine responses of children and older adults.